226-240 of 825
Differentiating gMG for Diagnostic Precision: The Role of Fatigable Weakness
NeuroFrontiersDifferentiating gMG for Diagnostic Precision: The Role of Fatigable Weakness
Developments in Schizophrenia Care: An Alternative to Dopamine Receptor Blockage
NeuroFrontiersDevelopments in Schizophrenia Care: An Alternative to Dopamine Receptor Blockage
Navigating Myasthenia Gravis in Adolescents and Young Adults
NeuroFrontiersNavigating Myasthenia Gravis in Adolescents and Young Adults
Quality of Life in Schizophrenia Patients: Challenges and Practical Approaches to Care
On the Frontlines of SchizophreniaQuality of Life in Schizophrenia Patients: Challenges and Practical Approaches to Care
Spotting the Signs: Early Identification and Management of Schizophrenia
On the Frontlines of SchizophreniaSpotting the Signs: Early Identification and Management of Schizophrenia
Silent Brain Damage in ATTR-CM: Exploring Neurological Impacts
Spotlight On ATTR-CMSilent Brain Damage in ATTR-CM: Exploring Neurological Impacts
- advertisement
Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
NeuroFrontiersRozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
Challenges in DMD: Understanding the Height Factor
NeuroFrontiersChallenges in DMD: Understanding the Height Factor
Schizophrenia Care: Improving Social Cognition and Motivation
On the Frontlines of SchizophreniaSchizophrenia Care: Improving Social Cognition and Motivation
FcRn Inhibitors: A Potential New Targeted Therapy Option
NeuroFrontiersFcRn Inhibitors: A Potential New Targeted Therapy Option
Examining Schizophrenia Risk: The Influence of B12 Levels in Early Pregnancy
NeuroFrontiersExamining Schizophrenia Risk: The Influence of B12 Levels in Early Pregnancy
- advertisement
Unseen Struggles: Impacts of Homelessness on Women with Schizophrenia
NeuroFrontiersUnseen Struggles: Impacts of Homelessness on Women with Schizophrenia
NKX019: A Potential New Frontier in Generalized Myasthenia Gravis Therapy
NeuroFrontiersNKX019: A Potential New Frontier in Generalized Myasthenia Gravis Therapy
Beyond Amyloid and Tau: A Multimarker Approach to Alzheimer's Detection
NeuroFrontiersBeyond Amyloid and Tau: A Multimarker Approach to Alzheimer's Detection















































